Suppr超能文献

非人类灵长类动物的水动力肢体静脉注射评估。

Evaluation of hydrodynamic limb vein injections in nonhuman primates.

机构信息

Department of Pediatrics and Department of Medical Genetics, Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.

出版信息

Hum Gene Ther. 2010 Jul;21(7):829-42. doi: 10.1089/hum.2009.172.

Abstract

The administration route is emerging as a critical aspect of nonviral and viral vector delivery to muscle, so as to enable gene therapy for disorders such as muscular dystrophy. Although direct intramuscular routes were used initially, intravascular routes are garnering interest because of their ability to target multiple muscles at once and to increase the efficiency of delivery and expression. For the delivery of naked plasmid DNA, our group has developed a hydrodynamic, limb vein procedure that entails placing a tourniquet over the proximal part of the target limb to block all blood flow and injecting the gene vector rapidly in a large volume so as to enable the gene vector to be extravasated and to access the myofibers. The present study was conducted in part to optimize the procedure in preparation for a human clinical study. Various injection parameters such as the effect of papaverine preinjection, tourniquet inflation pressure and duration, and rate of injection were evaluated in rats and nonhuman primates. In addition, the safety of the procedure was further established by determining the effect of the procedure on the neuromuscular and vascular systems. The results from these studies provide additional evidence that the procedure is well tolerated and they provide a foundation on which to formulate the procedure for a human clinical study.

摘要

给药途径正成为将非病毒和病毒载体递送至肌肉的关键方面,以便能够对肌肉疾病等进行基因治疗。虽然最初使用了直接肌内途径,但由于其能够同时靶向多个肌肉并提高递送和表达效率,血管内途径正受到关注。为了递送裸质粒 DNA,我们小组开发了一种流体动力学的肢体静脉程序,该程序涉及在目标肢体的近端部分放置止血带以阻断所有血流,并快速注入大量基因载体,以使基因载体外渗并进入肌纤维。本研究的部分目的是优化该程序,为人体临床研究做准备。在大鼠和非人灵长类动物中评估了各种注射参数,例如罂粟碱预注射、止血带充气压力和持续时间以及注射速度的影响。此外,通过确定该程序对神经肌肉和血管系统的影响,进一步确定了该程序的安全性。这些研究的结果提供了更多证据表明该程序具有良好的耐受性,并为制定人体临床研究的程序奠定了基础。

相似文献

1
Evaluation of hydrodynamic limb vein injections in nonhuman primates.
Hum Gene Ther. 2010 Jul;21(7):829-42. doi: 10.1089/hum.2009.172.
2
The mechanism of naked DNA uptake and expression.
Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X.
3
Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates.
Hum Gene Ther. 2001 Mar 1;12(4):427-38. doi: 10.1089/10430340150504046.
4
Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.
Hum Gene Ther. 2011 Jul;22(7):889-903. doi: 10.1089/hum.2010.160. Epub 2011 Apr 18.
6
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs.
Mol Ther. 2004 Aug;10(2):386-98. doi: 10.1016/j.ymthe.2004.05.004.
7
Progress toward a nonviral gene therapy protocol for the treatment of anemia.
Hum Gene Ther. 2007 Mar;18(3):269-85. doi: 10.1089/hum.2006.186.

引用本文的文献

2
DNA nuclear targeting sequences for enhanced non-viral gene transfer: An and study.
Mol Ther Nucleic Acids. 2021 Mar 19;24:477-486. doi: 10.1016/j.omtn.2021.03.012. eCollection 2021 Jun 4.
3
Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy.
Mol Ther Methods Clin Dev. 2019 Oct 14;15:294-304. doi: 10.1016/j.omtm.2019.10.002. eCollection 2019 Dec 13.
4
DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Mol Ther Methods Clin Dev. 2017 Oct 24;7:123-131. doi: 10.1016/j.omtm.2017.10.005. eCollection 2017 Dec 15.
5
A targeted controlled force injection of genetic material in vivo.
Mol Ther Methods Clin Dev. 2016 Mar 30;5:16016. doi: 10.1038/mtm.2016.16. eCollection 2016.
6
High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline.
Hum Gene Ther. 2015 Sep;26(9):614-21. doi: 10.1089/hum.2015.023. Epub 2015 Jul 30.
7
Gene therapy for muscular dystrophy: moving the field forward.
Pediatr Neurol. 2014 Nov;51(5):607-18. doi: 10.1016/j.pediatrneurol.2014.08.002. Epub 2014 Aug 7.
9
Autophagy as a new therapeutic target in Duchenne muscular dystrophy.
Cell Death Dis. 2012 Nov 15;3(11):e418. doi: 10.1038/cddis.2012.159.
10
Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.
Mol Ther. 2012 Feb;20(2):456-61. doi: 10.1038/mt.2011.137. Epub 2011 Jul 19.

本文引用的文献

2
3
Muscular gene transfer using nonviral vectors.
Curr Gene Ther. 2008 Oct;8(5):391-405. doi: 10.2174/156652308786070998.
5
Computer-assisted hydrodynamic gene delivery.
Mol Ther. 2008 Jun;16(6):1098-104. doi: 10.1038/mt.2008.66. Epub 2008 Apr 8.
7
Progress toward a nonviral gene therapy protocol for the treatment of anemia.
Hum Gene Ther. 2007 Mar;18(3):269-85. doi: 10.1089/hum.2006.186.
8
Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle.
Hum Gene Ther. 2007 Mar;18(3):257-68. doi: 10.1089/hum.2006.115.
9
Gene therapy progress and prospects: hydrodynamic gene delivery.
Gene Ther. 2007 Jan;14(2):99-107. doi: 10.1038/sj.gt.3302891. Epub 2006 Nov 30.
10
Rapid intravascular injection into limb skeletal muscle: a damage assessment study.
Mol Ther. 2006 Jan;13(1):229-36. doi: 10.1016/j.ymthe.2005.07.699. Epub 2005 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验